Thierry Soussi
#137,288
Most Influential Person Now
Researcher
Thierry Soussi's AcademicInfluence.com Rankings
Thierry Soussicomputer-science Degrees
Computer Science
#6365
World Rank
#6713
Historical Rank
Computational Linguistics
#1081
World Rank
#1095
Historical Rank
Machine Learning
#2043
World Rank
#2069
Historical Rank
Artificial Intelligence
#2300
World Rank
#2339
Historical Rank

Download Badge
Computer Science
Thierry Soussi's Degrees
- PhD Computer Science Université Paris Cité
- Masters Artificial Intelligence Stanford University
- Bachelors Computer Science Université Paris Cité
Similar Degrees You Can Earn
Why Is Thierry Soussi Influential?
(Suggest an Edit or Addition)Thierry Soussi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Database of p53 gene somatic mutations in human tumors and cell lines. (1994) (946)
- Assessing TP53 status in human tumours to evaluate clinical outcome (2001) (721)
- Structural aspects of the p53 protein in relation to gene evolution. (1990) (637)
- TP53 tumor suppressor gene: A model for investigating human mutagenesis (1992) (600)
- p53 Antibodies in the sera of patients with various types of cancer: a review. (2000) (577)
- Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation (1996) (541)
- APC gene: database of germline and somatic mutations in human tumors and cell lines (1996) (462)
- Multifactorial analysis of p53 alteration in human cancer: A review (1994) (394)
- The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. (2005) (387)
- Shaping genetic alterations in human cancer: the p53 mutation paradigm. (2007) (370)
- The p53 Tumor Suppressor Gene: From Molecular Biology to Clinical Investigation (2000) (322)
- Serum p53 antibodies as early markers of lung cancer (1995) (316)
- Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects (1997) (315)
- TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade (2014) (301)
- p53 Website and analysis of p53 gene mutations in human cancer: Forging a link between epidemiology and carcinogenesis (2000) (299)
- p53 mutation heterogeneity in cancer. (2005) (288)
- The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot. (1992) (286)
- Structural aspects of the p53 protein in relation to gene evolution: a second look. (1996) (283)
- Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas. (2019) (273)
- Mutant p53 protein localized in the cytoplasm inhibits autophagy (2008) (265)
- p53 alterations in human cancer: more questions than answers (2007) (252)
- Lymphomas in Patients With Sjögren's Syndrome Are Marginal Zone B-Cell Neoplasms, Arise in Diverse Extranodal and Nodal Sites, and Are Not Associated With Viruses (1997) (241)
- Analysis of the most representative tumour‐derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. (1994) (240)
- TP53: an oncogene in disguise (2015) (226)
- UMD (Universal Mutation Database): A generic software to build and analyze locus‐specific databases (2000) (216)
- p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series. (2000) (214)
- P53 Gene Mutation: Software and Database (1996) (188)
- Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface. (1993) (183)
- Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein (1997) (167)
- Cloning and characterization of a cDNA from Xenopus laevis coding for a protein homologous to human and murine p53. (1987) (167)
- Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment (2014) (166)
- The UMD‐p53 database: New mutations and analysis tools (2003) (164)
- TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations (2010) (158)
- Locus-specific mutation databases: pitfalls and good practice based on the p53 experience (2006) (154)
- Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein. (1994) (150)
- The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis (2012) (149)
- Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations (2005) (146)
- Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice. (2002) (146)
- Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer (1995) (144)
- Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma (2010) (137)
- Cancer and the heat shock response. (1994) (133)
- Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. (1997) (133)
- The UMD TP53 database and website: update and revisions (2006) (130)
- Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint (1999) (129)
- ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation (2018) (127)
- The humoral response to the tumor-suppressor gene-product p53 in human cancer: implications for diagnosis and therapy. (1996) (119)
- Significance of TP53 mutations in human cancer: A critical analysis of mutations at CpG dinucleotides (2003) (117)
- UMD (Universal Mutation Database): 2005 update (2005) (112)
- Epithelial HBL-100 cell line derived from milk of an apparently healthy woman harbours SV40 genetic information. (1985) (108)
- Primary proliferative T cell response to wild‐type p53 protein in patients with breast cancer (1995) (107)
- Nucleotide sequence of a cDNA encoding the rat p53 nuclear oncoprotein. (1988) (106)
- Can we predict solar ultraviolet radiation as the causal event in human tumours by analysing the mutation spectra of the p53 gene? (1994) (106)
- Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. (2006) (104)
- Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma. (1996) (104)
- Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination (2008) (104)
- Regulation of Mutant p53 Temperature-sensitive DNA Binding* (1996) (100)
- p53 mutation as a genetic trait of typical medullary breast carcinoma. (1999) (94)
- p53 antibodies in the sera of lung cancer patients: Comparison with p53 mutation in the tumour tissue (1995) (89)
- Detection and monitoring of serum p53 antibodies in patients with colorectal cancer. (1997) (89)
- Meta-analysis of the p53 Mutation Database for Mutant p53 Biological Activity Reveals a Methodologic Bias in Mutation Detection (2006) (87)
- Genetic alterations in localized prostate cancer: Identification of a common region of deletion on chromosome arm 18q (1994) (87)
- Database and software for the analysis of mutations in the human p53 gene. (1994) (84)
- Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors (2012) (83)
- Mutations in p53 produce a common conformational effect that can be detected with a panel of monoclonal antibodies directed toward the central part of the p53 protein. (1994) (80)
- Monitoring of p53 autoantibodies in lung cancer during therapy: relationship to response to treatment. (1998) (78)
- p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia. (1995) (78)
- Translocation of a store of maternal cytoplasmic c-myc protein into nuclei during early development (1989) (75)
- TP53 mutations in human cancer: database reassessment and prospects for the next decade. (2011) (75)
- Rainbow trout p53: cDNA cloning and biochemical characterization. (1992) (75)
- The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene. (2002) (72)
- The p53 tumour suppressor gene: a model for molecular epidemiology of human cancer. (1996) (70)
- Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients (2000) (69)
- Databases and software for the analysis of mutations in the human p53 gene, human hprt gene and both the lacI and lacZ gene in transgenic rodents (1998) (66)
- Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice. (2017) (64)
- P53 gene alterations in human tumors: perspectives for cancer control. (1997) (61)
- Squamous cell carcinomas after allogeneic bone marrow transplantation for aplastic anemia: further evidence of a multistep process. (1998) (60)
- Linear antigenic sites defined by the B-cell response to human p53 are localized predominantly in the amino and carboxy-termini of the protein. (1994) (59)
- Software and database for the analysis of mutations in the human FBN1 gene (1996) (59)
- p53 antibodies in the saliva of patients with squamous cell carcinoma of the oral cavity (1998) (59)
- Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan. (2019) (57)
- Splice mutations in the p53 gene: case report and review of the literature (2003) (56)
- ATF/CREB site mediated transcriptional activation and p53 dependent repression of the cyclin A promoter (1996) (55)
- The history of p53 (2010) (51)
- p53-mediated cellular response to DNA damage in cells with replicative hepatitis B virus. (1995) (51)
- Antibodies against p53 protein in serum of patients with benign or malignant pancreatic and biliary diseases. (1995) (50)
- The p53 pathway and human cancer (2005) (49)
- Versatile analysis of multiple macromolecular interactions by SPR imaging: application to p53 and DNA interaction (2004) (49)
- Change of Conformation of the DNA-binding Domain of p53 Is the Only Key Element for Binding of and Interference with p73* (2003) (45)
- Identification of cancer sex-disparity in the functional integrity of p53 and its X chromosome network (2019) (44)
- An endonuclease/ligase based mutation scanning method especially suited for analysis of neoplastic tissue (2002) (44)
- p53 mutations in BRCA1-associated familial breast cancer (1998) (44)
- Nucleotide sequence of a cDNA encoding the chicken p53 nuclear oncoprotein. (1988) (44)
- Evolutionary conservation of the biochemical properties of p53: specific interaction of Xenopus laevis p53 with simian virus 40 large T antigen and mammalian heat shock proteins 70 (1989) (43)
- p53 immunolabeling in archival paraffin-embedded tissues: optimal protocol based on microwave heating for eight antibodies on lung carcinomas. (1994) (42)
- Prognostic significance of serum p53 antibodies in patients with limited‐stage small cell lung cancer (2000) (42)
- Database of mutations in the p53 and APC tumor suppressor genes designed to facilitate molecular epidemiological analyses (1996) (40)
- Stabilization and expression of high levels of p53 during early development in Xenopus laevis. (1993) (39)
- Molecular Genetic Analysis of p53 Intratumoral Heterogeneity in Human Astrocytic Brain Tumors (2007) (38)
- Breast-cancer stromal cells with TP53 mutations. (2008) (38)
- ThinPrep®‐processed fine‐needle samples of breast are effective material for RNA‐ and DNA‐based molecular diagnosis (2003) (37)
- Production of human p53 specific monoclonal antibodies and their use in immunohistochemical studies of tumor cells. (1993) (37)
- Characterization of a bovine acidic FGF cDNA clone and its expression in brain and retina (1988) (36)
- Serum p53 antibodies: predictors of survival in small-cell lung cancer? (2000) (34)
- DNA-binding properties of the major structural protein of simian virus 40 (1986) (33)
- Recommendations for Analyzing and Reporting TP53 Gene Variants in the High‐Throughput Sequencing Era (2014) (32)
- Serum p53 antibodies in correlation to other biological parameters of breast cancer. (2003) (32)
- Erratum: Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas (Cell Reports (2019) 28(5) (1370–1384.e5), (S221112471930885X), (10.1016/j.celrep.2019.07.001)) (2019) (32)
- Serum p53 antibodies in patients with lung cancer: correlation with clinicopathologic features and smoking. (2003) (30)
- MUT‐TP53 2.0: a novel versatile matrix for statistical analysis of TP53 mutations in human cancer a (2010) (30)
- Emergence and evolution of TP53 mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide (2017) (29)
- p53 mutations and resistance to chemotherapy: A stab in the back for p73. (2003) (29)
- Rapid and Sensitive p53 Alteration Analysis in Biopsies from Lung Cancer Patients Using a Functional Assay and A Universal Oligonucleotide Array (2004) (28)
- A functional analysis of p53 during early development of xenopus laevis (1997) (28)
- Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate. (2019) (26)
- The UMD-p 53 Database : New Mutations and Analysis Tools (2003) (26)
- Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer? (2004) (26)
- Analysis of p53 antibody response in patients with squamous cell carcinoma of the head and neck. (1996) (24)
- Harmonized microarray/mutation scanning analysis of TP53 mutations in undissected colorectal tumors (2004) (23)
- Focus on the p53 gene and cancer: Advances in TP53 mutation research (2003) (23)
- Anti-apoptotic activity of p53 maps to the COOH-terminal domain and is retained in a highly oncogenic natural mutant (1999) (23)
- Xenopus laevis p53 protein: sequence-specific DNA binding, transcriptional regulation and oligomerization are evolutionarily conserved. (1995) (23)
- Advances in carcinogenesis: a historical perspective from observational studies to tumor genome sequencing and TP53 mutation spectrum analysis. (2011) (23)
- TP53 mutations are early events in chronic lymphocytic leukemia disease progression and precede evolution to complex karyotypes (2016) (22)
- Detection of p73 antibodies in patients with various types of cancer: immunological characterization (2001) (22)
- The TP 53 website : an integrative resource centre for the TP 53 mutation database and TP 53 mutant analysis (2012) (22)
- Regulation of the specific DNA binding activity of Xenopus laevis p53: evidence for conserved regulation through the carboxy-terminus of the protein (1998) (22)
- The cDNA cloning and immunological characterization of hamster p53. (1992) (22)
- Quantitative fish determination of chromosome 3 arm imbalances in lung tumors by automated image cytometry. (2004) (20)
- p53 and APC gene mutations: software and databases (1997) (20)
- Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas. (2019) (20)
- Seshat: A Web service for accurate annotation, validation, and analysis of TP53 variants generated by conventional and next‐generation sequencing (2018) (20)
- The TP53 Gene Network in a Postgenomic Era (2014) (19)
- High prevalence of cancer‐associated TP53 variants in the gnomAD database: A word of caution concerning the use of variant filtering (2019) (19)
- Stimulation of rat liver α‐ and β‐type DNA polymerases by an homologous DNA‐unwinding protein (1977) (18)
- Anti-p53 antibodies are rarely detected in serum of patients with rheumatoid arthritis and Sjögren's syndrome. (1999) (17)
- 3-Methylcholanthrene inactivates the p53 gene in Syrian hamster embryo fibroblasts by inducing a specific intronic point mutation. (1994) (17)
- Single-molecule DNA sequencing of acute myeloid leukemia and myelodysplastic syndromes with multiple TP53 alterations (2018) (17)
- Lack of HIN-1 Methylation Defines Specific Breast Tumor Subtypes Including Medullary Carcinoma of the Breast and BRCA1-Linked Tumors (2003) (17)
- P53 Gene Mutation: Software and Database (1998) (17)
- Serum p53 antibodies in small cell lung cancer: the lack of prognostic relevance. (2001) (17)
- Locus‐Specific Databases in Cancer: What Future in a Post‐Genomic Era? The TP53 LSDB paradigm (2014) (17)
- Squaramide-based synthetic chloride transporters activate TFEB but block autophagic flux (2019) (16)
- Analysis of p53 Gene Alterations in Cancer: A Critical View (2007) (16)
- Synonymous Somatic Variants in Human Cancer Are Not Infamous: A Plea for Full Disclosure in Databases and Publications (2017) (16)
- Absence of p53 germ-line mutations in bilateral breast cancer patients (1992) (16)
- Databases and software for the analysis of mutations in the human p53 gene, the human hprt gene and both the lacI and lacZ gene in transgenic rodents (1997) (16)
- Regulation of the cell cycle by p53 after DNA damage in an amphibian cell line (2001) (15)
- Medullary breast carcinoma: prognostic implications of p53 expression. (2003) (15)
- Detection and sequencing of p53 gene mutations in bronchial biopsy samples in patients with lung cancer. (1994) (15)
- Investigation and prediction of the severity of p53 mutants using parameters from structural calculations (2009) (15)
- [Bcl2-associated X protein]. (2001) (14)
- Data mining the p53 pathway in the Fugu genome: evidence for strong conservation of the apoptotic pathway (2003) (14)
- The Immune Response to p 53 in Breast Cancer Patients Is Directed against Immunodominant Epitopes Unrelated to the Mutational Hot Spot 1 (1992) (13)
- Database and software for the analysis of mutations at the human p53 gene. (1994) (12)
- ERIC recommendations for TP 53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results (2018) (12)
- p53 gene alterations in human hematological malignancies: a review. (1991) (12)
- Critical residues of epitopes recognized by several anti-p53 monoclonal antibodies correspond to key residues of p53 involved in interactions with the mdm2 protein. (2000) (12)
- APC gene: database of germline and somatic mutations in human tumors and cell lines (1998) (11)
- Functional characterization of Xenopus laevis p53: evidence of temperature-sensitive transactivation but not of repression (1994) (11)
- Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene (2020) (11)
- Genetic profiling of CLL: a ‘TP53 addict' perspective (2016) (10)
- Fam83F induces p53 stabilisation and promotes its activity (2019) (10)
- Reassessment of the p 53 mutation database in human disease by data mining with a library of p 53 missense mutations (2004) (9)
- Databases and software for the analysis of mutations in the human p53 gene, the human hprt gene and the lacZ gene in transgenic rodents (1996) (9)
- MUT‐TP53: a versatile matrix for TP53 mutation verification and publication (2006) (8)
- Germline mutations of the p53 tumor-suppressor gene in cancer-prone families: a review. (1993) (8)
- Survival Implications of the Relationship between Tissue versus Circulating Tumor DNA TP53 Mutations—A Perspective from a Real-World Precision Medicine Cohort (2020) (7)
- Functional analyses of a unique p53 germline mutant (y236Δ) associated with a familial brain tumor syndrome (1999) (7)
- [p53 mutations and resistance to chemotherapy: a stab in the back for p73?]. (2003) (7)
- Splice Mutations in the p 53 Gene : Case Report and Review of the Literature (2002) (7)
- Comprehensive assessment of TP53 loss of function using multiple combinatorial mutagenesis libraries (2020) (7)
- A monoclonal antibody against DNA binding helix of p53 protein (2001) (6)
- Monoclonal antibodies raised against Xenopus p53 interact with human p73 (2002) (6)
- MDM2-TP53 Crossregulation: An Underestimated Target to Promote Loss of TP53 Function and Cell Survival. (2018) (6)
- Very low incidence of p53 antibodies in adult non‐Hodgkin's lymphoma and multiple myeloma (1998) (6)
- Analysis of p 53 Antibodies in Patients with Various Cancers Define B-Cell Epitopes of Human p 53 : Distribution on Primary Structure and Exposure on Protein Surface 1 (2006) (6)
- Le dosage sérique des anticorps anti-p53: application au cancer colorectal (2000) (5)
- Genes and mechanisms involved in early embryonic development in Xenopus laevis. (1990) (4)
- Detection and monitoring of serum p 53 antibodies in patients with colorectal cancer (4)
- When mutant p53 plays hide and seek: a new challenge for diagnosis and therapy? (2009) (3)
- [P53 antibodies: a new method for the analysis of alterations of the p53 gene: application to breast cancer]. (1996) (3)
- The role of p53 in normal cells and in cancer development. (1997) (3)
- [P53 tumor suppressor gene]. (1993) (3)
- TP53 and 53BP1 Reunited. (2017) (3)
- [The p53 gene and protein in bronchial carcinogenesis:from biological to clinical aspects]. (1994) (3)
- Colorectal cancer is associated with the presence of cancer driver mutations in normal colon (2021) (3)
- [Serum p53 antibody assay: evaluation in colorectal cancer]. (2000) (3)
- Medullary Breast Carcinoma: Prognostic Implications of P53 Expression (2003) (2)
- Evolutionary history of the p53 family DNA-binding domain: insights from an Alvinella pompejana homolog (2022) (2)
- [Tumor suppressor p53 gene: a potential target for cancer therapy?]. (1997) (2)
- Le gène suppresseur de tumeur p53 (1997) (2)
- [Role of the p53 gene in human malignant tumors. A major discovery in oncology]. (1993) (2)
- [Genetic alterations in localized cancers of the prostate: identification of a common region of deletion on the chromosome 18q]. (1995) (2)
- Benign single-nucleotide polymorphisms in the coding region of TP53: finding the needles in a haystack of pathogenic variants. (2022) (1)
- Colorectal Cancer Is Associated with the Presence of Cancer Driver Mutations in Normal Colon. (2022) (1)
- A new set of monoclonal antibodies directed to proline-rich and central regions of p53. (2004) (1)
- [Genes and cancer. NBS1 (Nijmegen breakage syndrome). Repair gene]. (1999) (1)
- Chapter 12 ANALISYS OF P 53 GENE AALTERATIONS IN CANCER : A CRITICAL VIEW (2005) (1)
- Ultra-sensitive sequencing for cancer detection reveals progressive clonal selection in normal tissue over a century of human lifespan (2018) (1)
- Landscape of TP53 Alterations in Chronic Lymphocytic Leukemia via Data Mining Mutation Databases (2022) (1)
- Multifactorial analyasis of P53 alterations in human cancer (1993) (1)
- Author Correction: Squaramide-based synthetic chloride transporters activate TFEB but block autophagic flux (2019) (1)
- Prevalence, distribution and predictive value of XPO1 mutation in a real‐life chronic lymphocytic leukaemia cohort (2020) (1)
- Human double minute 2 (MDM2 in the mouse) - Oncoprotein (2000) (1)
- [Genes & cancer. Card no. 28: PTEN (MMAC, TEP-1) (phosphatase and tensin homolog deleted on chromosome 10)]. (1999) (1)
- [Record no. 23: hMLH1]. (1999) (1)
- [Li-Fraumeni syndrome and germ-line mutations of the p53 gene]. (1994) (1)
- Erratum to Morselli E, et al. Cell Cycle 2008; 7:3056–61 (2014) (1)
- [p53 and Rb, clinical and therapeutic perspectives]. (1993) (0)
- [Record no. 22: Beta-catenin]. (1999) (0)
- SMAD4/DPC4 (small mothers against decapentaplegic deleted in pancreatic carcinoma, locus 4): Gène suppresseur de tumeur (1998) (0)
- Gène Ret (REarranged during transfection) (1998) (0)
- The p53 Tumor Suppressor Gene in Lung Cancer: From Molecular to Serological Diagnosis (1998) (0)
- [Chart no 45 - WRN (RCQL3)]. (2001) (0)
- [INK4a-ARF (MTS1) or inhibitor of CDK-alternating reading frame (multiple tumor suppressor gene)]. (1999) (0)
- hCDC4 (FBW7, AGO, Archipelago) (2006) (0)
- The Broad Spectrum of TP53 Variants in CLL: NGS Analysis of 573 Pathogenic TP53 Variants (2019) (0)
- Gène anti-apoptotique : Bcl2 (B cell lymphoma) (1998) (0)
- Fumarate hydratase (fumarase, FH, EC4.2.1.2) (2006) (0)
- Detection andmonitoring ofserump53antibodies inpatients withcolorectal cancer (2011) (0)
- [Perspectives of practical application for studies of gene p53]. (1994) (0)
- Surface plasmon resonance based imaging system and some of its multiple biosensing applications (2003) (0)
- [Fli-1 (Friend leukemia integration 1). Oncogene]. (1998) (0)
- [File no. 40. DNA polymerase n (Pol H) in hRad30A. Repair gene]. (2000) (0)
- P53 (protein 53 kDa) (2011) (0)
- Atlas of Genetics and Cytogenetics in Oncology and Haematology (2003) (0)
- MET (c-met, hepatocyte growth factor receptor) (2005) (0)
- Oncogène : TAL1 (SCL) (T cell leukemia 1) (1998) (0)
- [File no. 41. VHL (von Hippel-Lindau). Tumor suppressor gene]. (2000) (0)
- [BLM (RCQL2) or Bloom Syndrome]. (2001) (0)
- Correlations between p53 overexpression, serum antibodies and gene mutation in colorectal cancer (1998) (0)
- Gene p 53 Human Database and Software for the Analysis of Mutations in the Updated (2006) (0)
- Gène PML (Promyelocytic Leukemia) (1999) (0)
- A monoclonal antibody against DNA binding helix of p 53 protein (2001) (0)
- p53 diagnosis in human cancer: what utility? (2001) (0)
- FLT3 (Stem cell tyrosine kinase 1, STK1, CD135 antigen) (2005) (0)
- TP53_PROF: a machine learning model to predict impact of missense mutations in TP53 (2022) (0)
- [44 .PMS2 (post meiotic segregation increased, S. cerevisiae 2]. (2001) (0)
- Fiche n°34 : Gène : hSNF5/INI1 (SMARCB1) ou sucrose non fermenting/integrase interactor SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily b, member 1 - Catégorie : Gène suppresseur de tumeur (2000) (0)
- [Case No. 36: E-cadherin (uvomorulin or CDH1]. (2000) (0)
- [File no.47: CMYC]. (2001) (0)
- EGFR (epidermal growth factor receptor), V-ERB-B, ERBB1 oncogène (2005) (0)
- [PML (promyelocytic leukemia). Oncogene]. (1999) (0)
- FINE EPITOPIC SPECIFICITY AND AFFINITY OF VARIOUS p53 MONOCLONAL ANTIBODIES (1996) (0)
- 765 Multifactorial analysis of p53 alteration in human cancer (1995) (0)
- p53 overexpression in node-negative breast cancer: Prognostic significance in a randomized study? (1997) (0)
- Methylcholanthrene Inactivates the p 53 Gene in Syrian Hamster Embryo Fibroblasts by Inducing a Specific Intronic Point Mutation 1 (2006) (0)
- [Genetics and cancer: fundamental and clinical aspects]. (2001) (0)
- Rb1 (rétinoblastome): Gène suppresseur de tumeur (1998) (0)
- Stimulation of rat liver alpha- and beta-type DNA polymerases by an homologous DNA-unwinding protein. (1977) (0)
- [Chart 48: FANCG/XRCC9 (type G Fanconi's anemia)]. (2001) (0)
- Abstract 2735: Clinico-pathological and molecular features associated with TP53 mutation in 3457 molecularly-profiled colorectal cancers (CRCs) (2016) (0)
- Gène RASSF1 (ras association domain family protein 1) (2005) (0)
- [Chart no. 30: FANCA (Fanconi's anemia type A). Repair gene?]. (1999) (0)
- TP53 (Tumour protein p53 (Li-Fraumeni syndrome)) (2018) (0)
- [Record no. 34: hSNF5/INI1 (SMARCB1)]. (2000) (0)
- [PTPC (Patched). Tumor suppressor gene]. (1999) (0)
- TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia (2022) (0)
- Fiche no. 32: ATM (ataxie telangiectasie mutated). (2000) (0)
- [Genes and cancers: c-Kit, SCFR (stem cell factor receptor) CD117]. (2001) (0)
- 399 P53 serum antibodies in head and neck SCC (1995) (0)
- Squaramide-based synthetic chloride transporters activate TFEB but block autophagic flux (2019) (0)
- Gène suppresseur de tumeur (2005) (0)
- Fiche no. 27: INK4a-ARF (MTS1) or inhibitor of CDK-alternative reading frame (multiple tumor suppressor gene). (1999) (0)
- [Immunochemistry and genotype analysis of tumors. Second part: What future for the molecular diagnosis of tumors?]. (2002) (0)
- [Record no. 39: p53 (TP53)]. (2000) (0)
- [Case No. 37: hdm2 (mdm2 in mice)]. (2000) (0)
- BRCA1 (breast cancer type 1): Gène suppresseur de tumeur (1998) (0)
- [Record no. 38: TGFBR2 (type II TGFbeta receptor)]. (2000) (0)
- Fam83F induces p53 stabilisation and promotes its activity (2019) (0)
- [Card no. 32: ATM (Ataxia Telangiectasia Mutated)]. (2000) (0)
- Dorian Gray mice exposed (1993) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Thierry Soussi?
Thierry Soussi is affiliated with the following schools: